We actively follow the best-practice guidelines of
The Better Business Bureau with a +A Rating
Transparent Pricing for Peptide Therapy
At Sky Health in Las Vegas, we believe in transparent, straightforward pricing. Your peptide therapy journey is designed in two clear phases to ensure you get the expert care you need without hidden recurring costs.
Your Initial Consultation & Onboarding
This is where your journey begins. Your first booking is a comprehensive dive into your health goals.
-
What’s Included: This covers your initial clinical expert review.
-
Consultation Fee: A one-time $99 USD fee is applied to this initial phase.
-
Variable Costs: Depending on your health profile, additional costs may apply if diagnostic blood work or specialized testing is required or requested to ensure your safety and results.
-
No Recurring Fees
Customized Patient-Centered Care
The Latest in Peptide Therapy
FDA-Approved Peptides for Consultation
Feeling low on energy or struggling with focus or recovery? At Sky Health Wellness Clinic in Las Vegas, our licensed medical team offers physician-supervised peptide therapies that include both FDA-approved medications and compounded formulations sourced from FDA-registered 503A & 503B pharmacies.
FDA-approved peptide medications, such as Semaglutide and Tirzepatide, are prescribed for their approved indications and administered under professional care. Compounded peptide formulations are not FDA-approved drugs and are provided only when medically appropriate and prescribed by a licensed clinician. Each plan is developed to support your health goals under careful supervision and transparency.
Peptides are used to target individual needs.
Medical Disclaimer
This page, including all descriptions of peptide therapies, is provided for informational purposes only and does not constitute medical advice. Peptide treatments should only be administered under the supervision of a qualified, licensed healthcare provider. Individual responses to therapy may vary, and outcomes cannot be guaranteed. To learn more, view our Legal Notice & Patient Responsibility section or visit our medical disclaimer page.
Peptide Therapy FAQ 2026
Precise Targeting of Chronic Issues
Help Improve Your Quality of Life
What is Peptide Therapy like at Sky Health?
Peptide therapy uses short chains of amino acids known as peptides to mimic and support natural hormones in your body. These targeted treatments regulate key functions such as appetite control, metabolism, energy levels, and hormone balance.
At Sky Health Wellness Clinic in Las Vegas, our medical providers offer physician-supervised peptide therapy as part of individualized wellness programs.
Our clinic offers both FDA-approved peptide medications, such as Semaglutide and Tirzepatide, and compounded peptide formulations from FDA-registered 503A & 503B pharmacies when medically appropriate. Licensed providers prescribe and monitor all treatments to ensure safety, transparency, and individualized care.
Peptide-based therapies may be incorporated into personalized care plans to help support wellness, metabolism, and overall health under medical supervision. Compounded peptide formulations are not FDA-approved drugs and are provided only when clinically indicated.
Personalized Peptide Innovations
Revolutionized Wellness
Benefits of Peptide Therapy
At Sky Health Wellness Clinic in Las Vegas, our medical providers offer physician-supervised peptide treatments designed to support specific health goals. We provide both FDA-approved peptide medications and compounded formulations sourced from FDA-registered 503A & 503B pharmacies when clinically appropriate.
While individual results vary, peptide-based therapies may be used under medical supervision to help support areas such as:
-
Metabolic Health: Managing weight and supporting healthy glucose metabolism through FDA-approved options like Semaglutide and Tirzepatide.
-
Recovery and Repair: Physician-directed use of select compounded peptides, when prescribed, may assist in general wellness or recovery goals.
-
Well-Being and Energy: Comprehensive programs developed by licensed clinicians to help patients feel their best under ongoing monitoring.
All peptide treatments at Sky Health are developed in accordance with medical oversight, transparent sourcing, and patient-specific evaluation. Compounded peptide formulations are not FDA-approved drugs and are offered only when medically necessary and prescribed by a licensed provider.
Before starting any peptide therapy, consult with our clinicians or your primary care provider to determine whether a peptide-based approach is appropriate for your care plan.
Discover the impact of this tailored approach by booking your customized peptide therapy session now.
Bremelanotide (PT-141) Peptide
Bremelanotide, commonly referred to as PT-141, is a synthetic peptide that interacts with melanocortin receptors involved in signaling pathways related to sexual arousal and neuroendocrine response. In the United States, Bremelanotide is FDA-approved only in its branded form (Vyleesi®) for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
PT-141 in non-branded, compounded, or research-labeled forms is not FDA-approved and should not be considered equivalent to the approved prescription medication. Any use outside the specific FDA-approved indication is considered off-label and requires careful clinician supervision.
At Sky Health Wellness Clinic, PT-141 may be discussed only within the context of medically supervised care. Treatment decisions are based on a full evaluation of individual needs, safety considerations, and regulatory guidelines.
What to Expect from PT-141 Therapy:
-
Clinical Evaluation: A licensed provider reviews health history, symptoms, and eligibility for Bremelanotide within its approved or investigational context.
-
Guided Administration: If prescribed, dosing and timing are supervised and adjusted based on patient tolerance and clinical considerations.
-
Monitoring and Follow-Up: Providers may evaluate response, side effects, or any reported changes to ensure safe use.
-
Educational Support: Patients receive information on lifestyle, relationship factors, and underlying contributors to sexual wellness.
Who May Be Considered for PT-141 Therapy:
-
Adult women who meet diagnostic criteria for HSDD and may be eligible for the FDA-approved form of Bremelanotide.
-
Individuals whose healthcare provider recommends further evaluation of sexual wellness concerns under medical supervision.
-
Adults exploring clinically supervised treatment options for sexual health or intimacy-related concerns.
-
Patients seeking structured therapeutic oversight for peptide-based care program
Important Legal and Regulatory Information:
-
FDA Approval: Only the branded version, Vyleesi®, is FDA-approved — and only for HSDD in premenopausal women.
-
Unapproved Forms: Compounded or research versions of PT-141 are not FDA-approved and may vary in purity, potency, and sterility.
-
Off-Label Use: Any use outside the FDA-approved indication requires physician oversight and informed consent.
-
Quality Assurance: Products from non-FDA-approved facilities or labeled for research-only use may not meet pharmaceutical manufacturing standards.
-
Military Members: U.S. service members should avoid PT-141 and other peptide hormones, as they are on the military's prohibited dietary supplement list.
At Sky Health Wellness Clinic, our goal is to provide safe, transparent, and evidence-based sexual health care. Bremelanotide is prescribed only for approved indications and under ongoing medical supervision to ensure patient safety and satisfaction.
%20Peptide%20Therapy%20Las%20Vegas.webp)
Semaglutide Peptide
Semaglutide is a GLP-1 receptor agonist that has been extensively studied for its effects on glucose regulation and metabolic pathways. It works by mimicking the action of the body’s natural incretin hormones, which influence insulin secretion, slow gastric emptying, and affect appetite signaling. In clinical practice, Semaglutide is used in its FDA-approved forms (Ozempic®, Wegovy®, and Rybelsus®) for specific indications related to type 2 diabetes and chronic weight management under appropriate medical supervision.
At Sky Health Wellness Clinic, Semaglutide may be incorporated into a patient’s care plan when clinically appropriate and prescribed by a licensed provider. All dosing, monitoring, and adjustments are carried out through structured medical oversight to support safety and individualized decision-making.
What to Expect from Semaglutide Therapy:
-
Medical Evaluation: A licensed provider reviews medical history, current medications, and eligibility for FDA-approved Semaglutide formulations.
-
Supervised Dosing: Treatment follows a gradual titration schedule to assess tolerance and minimize common gastrointestinal side effects.
-
Ongoing Monitoring: Follow-up visits may include reviewing symptoms, metabolic markers, and overall treatment response to guide any necessary adjustments.
-
Integrated Support: Patients may receive guidance related to nutrition, routine physical activity, and lifestyle habits that complement metabolic health goals.
Who May Be Considered for Semaglutide Therapy:
-
Adults with type 2 diabetes seeking improved glycemic control through an FDA-approved GLP-1 medication.
-
Individuals with obesity or overweight who meet eligibility criteria for chronic weight management with Semaglutide under medical supervision.
-
Patients referred by their primary care provider for structured metabolic health support.
-
Adults who benefit from clinician-supervised medication management as part of a broader wellness plan.
Important Legal and Regulatory Information for Semaglutide:
-
FDA-Approved Status: Semaglutide is FDA-approved only for specific formulations and indications (type 2 diabetes and chronic weight management). It cannot be marketed for non-approved uses.
-
No Compounded Substitutes: The FDA has stated that compounded Semaglutide is not the same as approved products. Some compounded versions may use salt forms or ingredients not permitted for compounding, creating safety and regulatory concerns.
-
Off-Label Use Requires Oversight: Any use of Semaglutide outside its approved indications is considered off-label and must follow individualized clinical judgment by a licensed provider.
-
Manufacturing and Quality Risks: Non-approved or non-regulated versions may contain inaccurate strengths, impurities, or unverified ingredients that pose safety risks.
-
Military Advisory: U.S. service members should avoid non-FDA-approved Semaglutide products. Ingredients found in unauthorized or compounded peptides may appear on the Department of Defense’s prohibited substances list and can result in adverse findings during readiness or medical screenings.
If you'd like to learn more, visit our learning center's Ultimate Guide to Semaglutide.
At Sky Health Wellness Clinic, Semaglutide is used only for its FDA-approved indications and within the scope of professional medical supervision. The goal is to provide clear, evidence-informed guidance so patients can make well-supported decisions about their metabolic health.
Sermorelin Peptide
Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH). It works by stimulating the pituitary gland to produce endogenous growth hormone, a natural hormone involved in metabolism, cellular repair, and developmental processes. Sermorelin has been studied for its role in evaluating pituitary function and for its potential to influence growth hormone dynamics in adults under certain clinical circumstances.
Although Sermorelin is sometimes used in wellness-oriented care plans, it is not FDA-approved for anti-aging, athletic performance, or body composition enhancement. Any use outside of its recognized diagnostic context is considered off-label and must be approached with careful clinical supervision.
At Sky Health Wellness Clinic, Sermorelin may be included in patient care only when a licensed provider determines it is appropriate and safe. All treatment decisions involve individualized assessment, laboratory review when indicated, and ongoing monitoring.
What to Expect from Sermorelin Therapy:
-
Clinical Evaluation: A provider reviews medical history, symptoms, and laboratory results to determine whether Sermorelin is appropriate for inclusion in a patient’s care plan.
-
Guided Administration: Dosing schedules are developed based on patient tolerance and clinical objectives, with adjustments made during follow-up visits.
-
Ongoing Monitoring: Providers may review changes in symptoms, sleep patterns, or general wellness to evaluate how a patient is responding.
-
Integrated Care: Patients may receive additional guidance regarding nutrition, activity, and lifestyle practices to support overall wellness.
Who May Be Considered for Sermorelin Therapy:
-
Adults with clinically identified growth hormone concerns evaluated under medical supervision.
-
Individuals seeking physician-directed support for wellness programs that incorporate hormone-modulating therapies.
-
Patients referred by their primary provider for diagnostic or adjunctive endocrine-related evaluation.
-
Adults who benefit from structured, clinician-managed treatment plans involving peptide-based therapies.
Important Legal and Regulatory Information:
-
Not FDA-Approved for Anti-Aging or Performance Use: Sermorelin is approved by the FDA only for the diagnostic evaluation of growth hormone secretion in children. It is not approved for anti-aging, athletic performance, body composition enhancement, or general wellness purposes.
-
Not Legal to Market as Therapy for Unapproved Uses: Sermorelin cannot be legally marketed, sold, or advertised in the U.S. as a treatment for aging, muscle growth, fat loss, vitality enhancement, or any non-approved indication. Its use in wellness settings is off-label and must be clinically justified by a licensed prescriber.
-
Investigational Compound in Adults: Safety, long-term effects, and efficacy of Sermorelin for adult wellness objectives have not been established through FDA-regulated human trials. Any use outside its approved scope should be approached with careful medical oversight.
-
Manufacturing and Quality Considerations: Potency, purity, and sterility may vary depending on the compounding pharmacy. Only pharmacies registered with the FDA and compliant with current good manufacturing practices (cGMP) should be used.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptide hormones, including Sermorelin. Many hormone-modulating compounds appear on the Department of Defense’s prohibited dietary supplement ingredients list and may trigger adverse findings in readiness or medical screenings.
If you'd like to learn more, visit our learning center's Ultimate Guide to Sermorelin.
At Sky Health Wellness Clinic, Sermorelin is used only under appropriate clinical supervision and with full transparency regarding its regulatory status. Our approach prioritizes safety, patient education, and evidence-informed guidance when incorporating peptide-based therapies into individualized wellness programs.
Tesamorelin Peptide
Tesamorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH). It has been studied for its ability to stimulate endogenous growth hormone production, which plays a role in metabolism, cellular repair, and various endocrine functions. Tesamorelin is FDA-approved only for the reduction of excess abdominal fat in adults with HIV-associated lipodystrophy and is not approved for general weight loss, anti-aging purposes, or athletic enhancement.
In clinical settings, Tesamorelin may be prescribed when a licensed medical provider determines that a patient meets eligibility criteria for its approved indication. Any use outside of its FDA-approved purpose is considered off-label and requires careful medical oversight.
What to Expect from Tesamorelin Therapy:
-
Medical Evaluation: A provider reviews medical history, current metabolic health, and any relevant laboratory findings to determine if Tesamorelin is appropriate within its approved context.
-
Dose Guidance: Treatment typically involves scheduled subcutaneous administration following a standardized protocol, with clinician-directed adjustments as needed.
-
Monitoring and Follow-Up: Providers may track patient response, review metabolic markers when appropriate, and assess overall tolerance during follow-up visits.
-
Supportive Lifestyle Review: Patients may receive general guidance on nutrition and activity patterns that complement metabolic wellness under clinical supervision.
Who May Be Considered for Tesamorelin Therapy:
-
Adults diagnosed with HIV-associated lipodystrophy who meet clinical criteria for the medication’s FDA-approved use.
-
Patients referred by a licensed healthcare provider for evaluation related to changes in body fat distribution within Tesamorelin’s studied context.
-
Individuals participating in medically supervised endocrine or metabolic care programs.
-
Adults requiring structured oversight for peptide-based therapies as part of a physician-guided health plan.
Who May Be Considered for Tesamorelin Therapy:
-
FDA-Approved for a Single Indication: Tesamorelin is approved exclusively for the treatment of excess abdominal fat in adults with HIV-associated lipodystrophy. It is not authorized for weight loss, anti-aging, or performance enhancement.
-
Off-Label Restrictions: Use outside the FDA-approved purpose requires clinician oversight, carries additional risk, and has not been validated through large-scale human trials.
-
Investigational Limitations: Long-term safety, metabolic outcomes, and broader clinical applications beyond the approved indication have not been established.
-
Manufacturing and Sourcing Considerations: Only pharmacy-dispensed formulations produced under regulated conditions should be used. Non-regulated online products increase the risk of impurities or inaccurate potency.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptides, including hormone-modulating compounds. Many appear on the Department of Defense’s prohibited dietary supplement list and may trigger adverse findings during readiness or medical screenings.
If you'd like to learn more, visit our learning center's Ultimate Guide to Tesamorelin.
At Sky Health Wellness Clinic, Tesamorelin is prescribed only for its FDA-approved indication and used within a framework of transparent, evidence-informed, and medically supervised care. Our focus is to help patients understand the scientific and regulatory background of peptide therapies so they can make informed decisions with their healthcare provider.
Schedule a consultation to discuss your endocrine profile and determine whether Tesamorelin may be appropriate for your individual care plan.
Tirzepatide Peptide
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for its effects on glucose regulation and metabolic function. It works by interacting with incretin pathways involved in insulin secretion, appetite signaling, and gastrointestinal transit. The medication is FDA-approved (Mounjaro®) for improving glycemic control in adults with type 2 diabetes and may also be prescribed for chronic weight management under FDA review and specific eligibility criteria.
At Sky Health Wellness Clinic, Tirzepatide may be considered as part of a medically supervised program when a licensed provider determines that an FDA-approved formulation is appropriate. Treatment is monitored through structured follow-up visits to ensure safe titration and individualized care.
What to Expect from Tirzepatide Therapy:
-
Medical Assessment: A clinician evaluates health history, diabetes status, BMI criteria, and overall suitability for Tirzepatide.
-
Guided Dose Adjustment: Treatment typically involves gradual dose escalation to assess tolerance and minimize gastrointestinal side effects.
-
Regular Monitoring: Follow-ups may include reviewing blood glucose trends, treatment response, and potential side effects to guide safe use.
-
Supportive Counseling: Patients receive guidance on nutrition, physical activity, and lifestyle practices that complement metabolic health goals under medical supervision.
Who May Be Considered for Tirzepatide Therapy:
-
Adults with type 2 diabetes who may benefit from an FDA-approved dual incretin medication for glycemic control.
-
Individuals with obesity or overweight who meet clinical criteria for consideration of weight-management therapy under medical direction.
-
Patients referred by their healthcare provider for medication-based metabolic support.
-
Adults seeking structured, clinician-supervised care related to metabolic wellness.
Important Legal and Regulatory Information for Tirzepatide:
-
FDA-Approved for Specific Indications: Tirzepatide is FDA-approved for improving glycemic control in adults with type 2 diabetes (Mounjaro®). It is not approved for cosmetic weight loss, anti-aging, or performance enhancement purposes.
-
Weight-Management Use Requires Eligibility: Prescribing Tirzepatide for chronic weight management is limited to FDA-approved formulations and only when strict clinical criteria are met. Any use outside approved pathways requires clinician oversight.
-
Off-Label Restrictions: Use beyond the FDA-approved indication carries additional risk, requires medical supervision, and lacks long-term safety validation outside approved contexts.
-
Investigational Limitations: Long-term metabolic, endocrine, or cardiovascular outcomes for non-diabetic or non-qualified populations have not been established in large-scale trials.
-
Manufacturing and Sourcing Risks: Non-regulated online products marketed as Tirzepatide may contain incorrect potency, impurities, or harmful additives. Only pharmacy-dispensed, FDA-regulated formulations should be used.
-
Military Advisory: U.S. service members should avoid non-FDA-approved peptide or hormone-modulating compounds. Many appear on the Department of Defense prohibited ingredients list and may trigger adverse findings in readiness or medical screenings.
If you'd like to learn more, visit our learning center's Ultimate Guide to Tirzepatide.
At Sky Health Wellness Clinic, Tirzepatide is prescribed only for FDA-approved uses and within the scope of appropriate clinical supervision. Our role is to provide clear, evidence-informed guidance to support patient understanding and safe participation in metabolic health programs.
Legal Notice & Patient Responsibility
This page, including all descriptions of peptide therapies, is provided for informational purposes only and does not constitute medical advice. Peptide treatments should only be administered under the supervision of a qualified, licensed healthcare provider. Individual responses to therapy may vary, and outcomes cannot be guaranteed. All patients are required to review and sign a liability waiver before treatment can begin. Visit our full medical disclaimer for more information.
Risks and Side Effects
All medical procedures involve risks. Possible side effects of peptide therapy may include injection site reactions, allergic responses, or interactions with other medications or health conditions. You should consult your primary care provider before proceeding with any treatment.
Medical Supervision & Eligibility
Our clinic provides peptide therapy only when prescribed by a licensed provider. Some peptides may not be FDA-approved for all uses, and using them for unapproved purposes may carry regulatory or legal risk.
No Guarantee of Results
While peptide therapy may support wellness objectives, no specific outcomes can be assured.
Liability Release
By participating in peptide therapy at Sky Health Wellness Clinic, you accept responsibility for the treatment and agree to release and indemnify the clinic, its providers, and related parties from liability for any adverse events—except where caused by proven gross negligence or willful misconduct.
Governing Law
These terms are governed by the laws of Nevada. Any disputes will be resolved via binding arbitration in Clark County, Nevada. You waive the right to a jury trial in all related matters.
Warning for Military Personnel
Military members: U.S. service members should avoid peptide hormones and other non-FDA-approved peptide products. Many peptides appear on the Department of Defense’s prohibited dietary supplement list and may lead to disqualification, disciplinary action, or adverse findings during medical or readiness screenings.